ICOP shares rise 1% on strong H1 2025 results with backlog exceeding expectations

ICOP reported stronger-than-expected H1 2025 results, driving a 1% share increase. The company's backlog reached EUR1.27 billion, 15% above estimates, enhancing operational visibility, while revenue and EBITDA grew 104% and 57% year-over-year, respectively, both exceeding analyst projections. Despite a normalized project mix leading to a 5-percentage-point EBITDA margin decline, ICOP's net debt was better than expected due to higher cash reserves, likely earmarked for the Palingeo takeover bid.

Analysis

ICOP reported a strong H1 2025, with key performance metrics surpassing analyst consensus and driving a 1% share increase. The company's backlog grew to EUR1.27 billion, a significant 15% beat against the EUR1.1 billion estimate, which materially enhances earnings visibility for the next two years. This operational strength was reflected in top-line growth, with revenue surging 104% year-over-year, 3% above forecasts. EBITDA followed suit, increasing 57% YoY and beating estimates by 5%. However, profitability was tempered by a 5-percentage point decline in the EBITDA margin, a development attributed to a normalized project mix that now aligns with the composition of the current backlog. On the balance sheet, the net debt position was better than expected, although gross debt was slightly elevated. The company is maintaining higher-than-projected cash reserves, a strategic move likely in preparation for the mandatory takeover bid on Palingeo's minority shareholders and to manage working capital needs.

Key Decisions for Investors

• The 15% beat on the order backlog provides significant two-year revenue visibility, suggesting investors should re-evaluate forward earnings estimates to the upside.
• Investors should monitor the EBITDA margin to confirm that the 5-percentage point contraction is a stable result of the new project mix and not a sign of ongoing profitability erosion.
• The prudent cash management ahead of the Palingeo takeover is a positive signal, but investors must now scrutinize the execution and integration of the acquisition for synergies to be realized.
• Given the strong operational outperformance across revenue, EBITDA, and backlog, the modest 1% share price reaction may present a buying opportunity if the market has not fully priced in the enhanced long-term visibility.